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ABSTRACT
Aim: The aim of the present study was to screen soil and endophytic fungi for production
of lovastatin.
Methodology: Soil fungi were isolated by dilution plating technique and endophytic fungi
from selected medicinal plants by using standard procedures. All isolates were tested for
lovastatin production by Solid State Fermentation (SSF) using wheat bran as substrate.
Results: The soil isolate, Aspergillus terreus NCBI (KM017963) showed positive for
lovastatin (1.0 mg/G DWS) whereas none of the endophytic fungi tested showed
positivefor lovastatin production.
Keywords: Aspergillus terreus; endophytic fungi; Lovastatin; soil fungi.
1. INTRODUCTION
Lovastatin, a fungal secondary metabolite, acts as one of the competitive inhibitors of the
enzyme hydroxyl methyl glutaryl coenzyme A (HMG-CoA) reductase, which catalyses the
conversion of HMG CoA to mevalonate during cholesterol biosynthesis.  Because of this
nature, lovastatin finds its role in biomedical applications such as, in treatment of coronary
heart diseases, renal diseases, Alzheimer’s disease, bone fractures etc. Lovastatin has also
been used as a potential therapeutic agent for the treatment of various types of tumors
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because of its ability to suppress tumor growth in-vivo [1]. The antifungal activity of various
statins against yeasts are also reported for Candida albicans, Candida glabrata, Candida
krusei, Candida parapsilosis, Candida tropicalis, Cryptococcus neoformansand
Saccharomyces cerevisiae [2].
Several fungal genera including Aspergillus, Penicillium, Monascus, Paecilomyces,
Trichoderma, Scopulariopsis, Doratomyces, Phoma, Pythium, Gymnoascus and Hypomyces
are reported as lovastatin producers. However, only Aspergillus terreus has thus far been
used in commercial production [3,4]. A marine Actinomycete has also been reported to
produce lovastatin [5]. It is also naturally produced by certain higher fungi such as, Pleurotus
ostreatus (oyster mushroom) and closely related Pleurotus species. Although, the potential
of different classes of fungi to produce lovastatin is well documented, none of them have
been utilized in commercial scale production. Commercial lovastatin production was carried
out by Submerged Fermentation (SmF) and of-late its production using Solid State
Fermentation (SSF) is being investigated due to several advantages [6,7,8].
Endophytic fungi, the organisms that inhabit healthy living tissue of plant without causing any
harm, have been widely studied for their ability to produce an array of secondary metabolites
which are of commercial importance. Although it is well documented that secondary
metabolites produced by endophtyes possess anticancer (Paclitaxel), antibiotic
(Cryptocandin), anti-oxidant (Pestacin), immunosuppressive (Subglutinol A and B) and
antidiabetic (2,6-di-tert-butyl-p-cresol) properties[9] , there is no report available till date on
the production of anti-cholesterol drug, lovastatin. Therefore, an attempt was made in the
present study to evaluate the ability of endophytic fungi to produce lovastatin and, if
produced, their suitability for solid state fermentation.
2. MATERIALS AND METHODS
2.1 Isolation and Identification of Soil Fungi
Soil samples were collected in sterile containers from various regions of Bangalore,
Karnataka, India and serially diluted up to 10-6. The serially diluted soil samples were plated
onto Potato Dextrose Agar (PDA) supplemented with 50mg/L tetracycline to suppress the
bacterial growth and incubated at 37ºC for 3-4 days until fungal growth was noted. Each
isolate was sub-cultured and maintained on PDA slants [10]. Fungal identification was done
as described by Subramanyam, 1982 [11].
2.2 Isolation and Identification of Endophytic Fungi
The following medicinal plants Piper nigrum, Garcinia cambogia, Commiphora wightii,
Coleus aromaticus,Vetiveria zizanoides, Curcuma amada, Patchouli pogestemon and
Terminalia arjuna were collected from University of  Agricultural Sciences (UAS) GKVK,
Bangalore and Irinjalakida town, Thrissur Dist, Kerala, India. Various parts of fresh plants
(stem, leaf, roots) were cut into small pieces using sterile blade and washed with sterile
distilled water. The samples were then surface sterilized by dipping into 4% sodium
hypochlorite for 60 seconds and 70% ethanol for 5 seconds, rinsed with sterile water and
allowed to dry under sterile conditions. The samples were placed on Potato Dextrose Agar
(PDA) plates amended with 50mg/L tetracycline to suppress the bacterial growth and
incubated at 28ºC - 30ºC for 2 to 3 days. The hyphal tip of endophytic fungi growing out from
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the plant tissue was transferred to fresh PDA plates amended with 50mg/L tetracycline [12].
Endophytes were identified as described by Barnett and Hunter., 1982 [13].
2.3 Solid State Fermentation
Wheat bran was used as a sole source of substrate for lovastatin production. Two grams of
substrate was weighed and relative humidity was maintained at 70%. One milliliter of spore
suspension (106 spores) was added to the sterilized substrate and incubated at 28ºC [14].
2.4 Extraction
After ten days of incubation, the solid substrate was dried at 40ºC for 24 hrs, crushed and
extracted with 10ml ethyl acetate by shaking at 180 rpm for 2 hrs followed by filtration
through Whatman No. 1 paper. To 1ml of extract, 1ml of 1% trifluroacetic acid was added
and incubated for 10 minutes (lactonization of hydroxyl acid form of lovastatin). The filtrate
was then spotted onto Thin Layer Chromatography (TLC) for detecting the presence of
lovastatin in crude extract [15].
2.5 Thin Layer Chromatography
The extracted organic phase was concentrated to about 50μl using a block heater adjusted
to 45ºC, applied to a heat activated 20 × 20cm silica gel TLC plates. Dichloromethane and
ethyl acetate (70:30, v/v) were used as mobile phase. All the plates were observed under a
hand-held UV lamp (254nm) after developing three times in the same mobile phase and
stained afterward with iodine vapour. For each TLC run, lovastatin authentic standard
(Merck) was also included for Rf value comparison and confirmation [16].
2.6 High Performance Liquid Chromatography (HPLC)
For HPLC, a ODS (250mm x 4.6mm I.D micro metre) column with diode array detector was
used. Acetonitrile and phosphoric acid (60:40 v/v) were used as mobile phase. The eluent
flow rate was maintained at 1.5ml per minute and detection carried out at 238nm with
injection volume of 20 μl14. The production of lovastatin is expressed in µg/G dry weight
substrate (DWS). The yield of lovastatin was calculated according to the published method
[17]. Mevinolin (M2147) (Sigma-Aldrich, Germany) was used as standard.
2.7 Molecular Identification
Fungi were grown in 50 ml Potato Dextrose Broth for 5-6 days at 28ºC. The mycelia was
harvested and washed with distilled water and ground with liquid nitrogen. The nucleic acid
was extracted using Cetyltrimethyl ammonium bromide (cTAB) method. Polymerase chain
reaction was done using universal primers ITS1 and ITS4. BLAST analysis was done with
available NCBI database and the sequences submitted to NCBI [18].
3. RESULTS AND DISCUSSION
Lovastatin, a pharmaceutically important chemical compound has long been used for the
treatment of hypercholesterolemia. It is a secondary metabolite produced during the
secondary phase of fungal growth. The soil fungus Aspergillus terreus which was originally
discovered as lovastatin producer in 1979 has been used in the commercial production of
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lovastatin after obtaining clearance from Food and Drug Administration (FDA) in 1987 [19].
This is the only fungal isolate that has been utilized in the commercial level production of
lovastatin.
Continued search for microorganisms may offer potential candidates that could produce still
higher levels of lovastatin. Therefore, there is a need to explore other microbial habitats such
as, those living internal tissues of plants for novel and potent microorganisms. Fungal
endophytes (i.e) the fungi growing within plant tissues without causing any signs of harmful
symptoms or disease, are known to produce diverse bioactive secondary metabolites. These
metabolites exert bioactivity against cancer cell lines, pathogenic bacteria, fungi and also
against eukaryotic parasites such as Malaria, Leismaniasis and Chagas disease [20]. It is
well documented that the metabolites produced by endophytes generally exhibit diverse
range of structures including alkaloids, terpenoids, quinones, xanthones and phenols [21].
Therefore, the present study was undertaken to screen available endophytic fungi from
medicinal and soil fungi for their ability to produce lovastatin.
The procedures used for the isolation of fungi from plants and soil yielded fungal colonies
that were purified to obtain pure cultures. Of the fifty four endophytic fungi isolated from eight
different medicinal plants (Table 1), 41% belonged to the genus Aspergillus, 12.5% to
Penicillium, 17.8% to Fusarium, 8.92% to Cladosporium, 3.5% to Phomopsis, 3.5 % to
Pestalotiopsis, 3.5% to Collectotrichum and 8.9% to the group mycelia sterilia.
Among the 360 fungi isolated from soil, Aspergillus spp were dominant (50%) followed by
Penicillium spp. (25%). The remainder of the proportion belonged to the genus Fusarium,
Trichoderma, Rhizopus, Mucor, Cunninghamellawith a few sterile mycelia (Table 2).All
fungal isolates were screened for lovastatin production with wheat bran as solid substrate
under the conditions described in the methods section. At the end of the incubation period,
the cultures were processed for lovastatin extraction and HPLC analysis.
Few species of Aspergillus (180 isolates) produced varying levels of lovastatin as indicated
in Table 2. Of the fifteen A terreus strains isolated, three strains of Aspergillus terreus i.eL1,
L2 and L3 produced 1.0mg/G DWS (Dry Weight Substrate), 0.680 mg/G DWS and 0.330
mg/G DWS of lovastatin, respectively and A terreus L 1 which showed better yield (Fig. 2b)
was taken for further study.
Aspergillus terreus L 1 was identified by molecular methods.  The sequence was submitted
to NCBI (accession number KM017963). Thin Layer Chromatography analysis revealed the
presence of UV fluorescent spot at an Rf value of 0.67 which coincided with the authentic
lovastatin indicating the presence of lovastatin in A. terreus L 1 (NCBI-KM017963) extracts
(Fig. 1).
Our results are in agreement with published reports that Aspergillus terreus is the best
producer of lovastatin [3,19].  According to Jaivel and Marimuthu, and Raghunath et al., the
yield of Lovastatin in a strain of A terreus JPM3 and A niger similar such yield i.e 0.980mg/G
DWS [14,22]. Although the substrates in which they were grown were different.
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Table 1. List of endophytic fungi isolated from medicinal plants
No. Plant source Part of plant Organism
1 Piper nigrum stem Aspergillus sp
Fusarium sp
Aspergillus sp
Penicillium sp
Phomopsis sp
leaf Aspergillus sp
Penicillium sp
root Aspergillus sp
Penicillium sp
Fusarium sp
Aspergillus sp
2 Garcinia cambogia stem Cladosporium sp
Aspergillus sp
root Fusarium sp
Aspergillus sp
Pestalotiopsis sp
3 Commiphora wightii stem Fusarium sp
Aspergillus sp
root Fusarium sp
Fusarium sp
Aspergillus sp
Phomopsis sp.
4 Coleus aromaticus stem Aspergillus sp
leaf Aspergillus sp
root Penicillium sp
Aspergillus sp
5 Vettiveria zizanoides leaf Aspergillus sp
Cladosporium sp
Sterile mycelium
Fusarium sp
Pestalotiopsis sp
6 Curcuma amada stem Sterile mycelium
Cladosporiumsp
Aspergillus sp
leaf Cladosporium sp
Sterile mycelium
Fusarium sp
Aspergillus sp
7 Patchouli pogestomon stem Penicillium sp
Penicillium sp
Aspergillus sp
leaf Penicillium sp
Aspergillus sp
Aspergillus sp
Aspergillus sp
Colletotrichum sp
8 Terminalia arjuna stem Aspergillus sp
Aspergillus sp
Fusarium sp
Colletotricum sp
leaf Fusarium sp
Cladosporium sp
Aspergillus sp
Aspergillus sp
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Table 2. Production of lovastatin by soil fungi
No. Genus Number of
isolates
Isolate Yield
mg/G DWS
1 Aspergillus sp 180 Aspergillus terreus(L1)
Aspergillus terreus(L2)
Aspergillus terreus (L3)
Aspergillus sp (L4)
Aspergillus sp(L5)
Aspergillus sp(L6)
1.0
0.680
0.330
0.220
0.180
0.150
2 Penicillium sp 90 --- ---
3 Fusarium sp 18 --- ---
4 Trichoderma sp 25 --- ---
5 Cunninghamella sp 4 --- ---
6 Rhizopus sp 18 --- ---
7 Mucor sp 18 --- ---
8 Sterile mycelia 7 --- ---
Fig. 1.  TLC of extracts: Lane 1: Aspergillus terreus; soil isolate (NCBI KM017963);
Lane 2: Lovastatin standard: Lane 3: Endophtyic fungi extract
1              2              3
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HPLC analysis of the extracted lovastatin in comparison with the authentic lovastatin
(Fig. 2a) showed the presence of prominent lovastatin peak in the HPLC profile at 11.4 min
(retention time) in addition to other metabolites that was present in the crude extract.
It is of interest that none of the 54 endophytic fungi isolated from medicinal plants and
screened showed detectable levels of lovastatin production even after 10 days of incubation
(Fig. 1 and Fig. 2c). Whether or not the lack of lovastatin production by all endophytic fungi
screened in this study is a general feature of those isolated from medicinal plants remains to
be seen.  While these results enable us to conclude most, if not all, endophytic fungi may not
be the potential candidates for lovastatin production, the results are of considerable
importance in view of their endophytic (symbiotic) relationship with their host plants.
Fig. 2a
Fig. 2a. Lovastatin standard
Fig. 2b
Fig. 2b. Aspergillus terreus L1 (NCBI-KM017963): A soil isolate
LOVASTATIN
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Fig. 2c
Fig. 2c. Aspergillus sp. isolated from Piper nigrum (an endophyte)
Fig. 2. HPLC analysis of lovastatin
Lovastatin is a known inhibitor of the enzyme, HMG CoA reductase, an enzyme involved in
cholesterol biosynthesis and thus elicited interest in biomedical applications. In plant
systems on the other hand, HMG CoA reductase inhibits the synthesis of plant growth
promoting substances such as ABA, gibberellins, ubiquinone, carotenoids and isopyrenoids
[23,24] by the inhibition of mevalonate production. Indeed, the inhibition of HMG CoA
reductase and growth of Tobacco cells was observed by low concentrations of lovastatin and
reversal of such inhibition by Cytokinin has also been reported [25].
Endophytes are microorganisms that are endo-symbionts residing in plants at least during
part of their life cycle without any harm [26]. In view of the fact that none of the fifty four
endophytic fungi isolated from medicinal plants and screened in this study produced
detectable levels of lovastatin combined with the fact that the inhibition of plant growth by
lovastatin [25], the lack of lovastatin production by endophytic fungi appears to solely not to
harm the plant host system they are residing in.
4. CONCLUSION
Terrestrial species of Aspergillus, Penicillium, Monascus, Paecilomyces, Trichoderma,
Scopulariopsis, Doratomyces, Phoma, produce lovastatin while endophytic species of the
same genera do not, indicating that these endophytic fungi may not have necessary genetic
machinery to produce lovastatin or regulated differently. While the endophyte/plant
relationships are not clearly understood as compared to typical symbionts, the present study
has thrown some light towards the understanding of endophytic fungi and medicinal plant
relationship.
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